Abstract
Aims: To develop time‐dependent dose–response models for highly pathogenic avian influenza A (HPAI) of the H5N1 subtype virus.
Methods and Results: A total of four candidate time‐dependent dose–response models were fitted to four survival data sets for animals (mice or ferrets) exposed to graded doses of HPAI H5N1 virus using the maximum‐likelihood estimation. A beta‐Poisson dose–response model with the N 50 parameter modified by an exponential‐inverse‐power time dependency or an exponential dose–response model with the k parameter modified by an exponential‐inverse time dependency provided a statistically adequate fit to the observed survival data.
Conclusions: We have successfully developed the time‐dependent dose–response models to describe the mortality of animals exposed to an HPAI H5N1 virus. The developed model describes the mortality over time and represents observed experimental responses accurately.
Significance and Impact of the Study: This is the first study describing time‐dependent dose–response models for HPAI H5N1 virus. The developed models will be a useful tool for estimating the mortality of HPAI H5N1 virus, which may depend on time postexposure, for the preparation of a future influenza pandemic caused by this lethal virus.
Keywords: disease(s), infection, modelling, virulence, virus(es)
Introduction
Influenza A viruses are members of the family Orthomyxoviridae, which comprises enveloped viruses with segmented, negative‐sense RNA genomes (Wright et al. 2007). Based on the antigenicity of the two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA), influenza A viruses are currently divided into 16 HA and 9 NA subtypes, designated as H1–H16 and N1–N9. Over the past century, only viruses of the H1N1, H2N2, H3N2 and H1N2 subtypes have circulated in humans (Wright et al. 2007). Highly pathogenic avian influenza A (HPAI) of the H5N1 subtype viruses cause severe disease in humans, characterized by rapidly progressive pneumonia, multiorgan dysfunction and high mortality rate of more than 50% (Neumann et al. 2010). Since 2003, they have spread across large parts of the globe and continued to cause sporadic human infections. Although HPAI H5N1 viruses fortunately have not acquired the ability for efficient infection in and transmission between humans, statistical evidence of human‐to‐human transmission has been obtained from epidemiological studies (Yang et al. 2007), suggesting the potential to acquire the ability of sustained human‐to‐human transmission. To prepare for the worst (namely, the occurrence of an influenza pandemic by this lethal virus), it is essential to evaluate the infectivity and pathogenicity of HPAI H5N1 virus.
Quantitative microbial risk assessment (QMRA) framework can be a powerful tool to understand how to control pandemics mediated by environmental reservoirs or human‐to‐human transmission (e.g. calculating the risk of infection because of a low dose). An essential step in the QMRA process is dose–response assessment (Haas et al. 1999). Dose–response relationships have been investigated for many types of pathogens, e.g. Escherichia coli O157:H7, rotavirus, Cryptosporidium parvum (1993, 2000; Teunis et al. 2002), by predicting the response from exposure to a given dose. Recently, the time‐dependent dose–response models have been developed for improving postexposure decision‐making and/or for estimating exposure time for a point‐source outbreak, and they were proposed as an advanced approach for future QMRA frameworks (Huang and Haas 2009a; Huang et al. 2009b). As the mortality of humans infected with HPAI H5N1 virus is dependent on the days postexposure, based on the clinical observations (Liem et al. 2009), it is desirable to utilize time‐dependent dose–response model for assessing and characterizing the risks of HPAI H5N1 virus infection to humans. However, to date, none of the prior studies investigated the dose–response relationship to describe HPAI H5N1 virus infection.
This study was performed on the basis of the above‐mentioned background to develop time‐dependent dose–response models for HPAI H5N1 virus to describe mortality that depends on time postexposure.
Methods
Source of data
There are no data sets challenging humans with wild‐type HPAI H5N1 virus, because of its extreme high pathogenesis and mortality. Therefore, we used the alternative data sets describing pathogenesis of the virus to mice and ferrets as mammalian models (data set nos. 1–4), as described in Table 1. Briefly, the animals were intranasally or intratracheally inoculated with wild‐type HPAI H5N1 virus, and the time‐dependent response data were then obtained by monitoring the mortality of the animals (Fan et al. 2009; van den Brand et al. 2010; Wang et al. 2010; Kiso et al. 2011). These data sets include different experimental conditions of hosts, virus strains and inoculation routes.
Table 1.
Data set no. | Virus strain | Host | Exposure | No. of dose point | No. of time point | No. of animals per group | Reference |
---|---|---|---|---|---|---|---|
1 | A/duck/Guangxi/35/01 | BALB/c mice | Intranasal | 6 | 14 | 5 | Fan et al. 2009 |
2 | A/Hanoi/30408/2005 | BALB/c mice | Intranasal | 7 | 21 | 4 | Kiso et al. 2011 |
3 | A/Vietnam/1203/04 | Ferrets | Intranasal | 2 | 11 | 12 | Wang et al. 2010 |
4 | A/Indonesia/5/2005 | Ferrets | Intratracheal | 2 | 6 | 6 | van den Brand et al. 2010 |
Candidate dose–response models based on time dependency
It is well known that the exponential and the beta‐Poisson models provide good fits for microbial dose–response data, and these models have been used widely for risk assessment (Haas et al. 1999). The equations of exponential and beta‐Poisson models are shown as (1), (2), respectively.
(1) |
(2) |
where represents the probability of infection at the dose of , , , are parameters specific for the pair of host and pathogen.
As survival of animals exposed to HPAI H5N1 virus was dependent on days postinoculation (DPI) (Fan et al. 2009; van den Brand et al. 2010; Wang et al. 2010; Kiso et al. 2011), the classical dose–response models were expanded to incorporate DPI dependency by including additional parameters. The classical exponential and beta‐Poisson models were expanded to include exponential‐inverse or exponential‐inverse‐power time dependencies into k and N 50 values, respectively, and they were assumed as candidate time‐dependent models (Table 2).
Table 2.
Model description | DPI‐dependent parameter | DPI‐dependent dose–response model | References | |
---|---|---|---|---|
Basic model | DPI dependency | |||
Exponential | Exponential‐inverse | (3a) | (3b) | Huang and Haas 2009a; Huang et al. 2009b |
Exponential‐inverse‐power | (4a) | (4b) | This study | |
beta‐Poisson | Exponential‐inverse | (5a) | (5b) | Huang and Haas 2009a; Huang et al. 2009b |
Exponential‐inverse‐power | (6a) | (6b) | This study |
DPI, days postinoculation.
Estimation of the parameters of time‐dependent dose–response models
The candidate models were then applied for parameter estimation, as described previously (Huang and Haas 2009a; Huang et al. 2009b). Briefly, maximum‐likelihood estimation (MLE) method (Haas et al. 1999) implemented into the R programming language (http://www.r-project.org) was used to fit candidate models to observed data. For both the exponential and the beta‐Poisson models, the Broyden–Fletcher–Goldfarb–Shannon algorithm was used for optimization. The goodness of fit for the two models was determined based on their likelihoods, by comparing the deviances with the critical values of the chi‐squared distribution at a 95% confidence level , where df is the degree of freedom, m is the number of doses and n is the number of parameters. An acceptable fit must have a deviance lower than . To determine a better model, the differences in deviances between two models were compared with the 95% confidence value of chi‐squared distribution at a degree of freedom equal to the difference in parameter numbers between these two models ( , where is the difference in the degrees of freedom between two models).
Results
Identification of best‐fit model
To identify the best model to describe time‐dependent dose–response relationship for HPAI H5N1 virus, the survival data listed in Table 1 were fitted to each of four candidate time‐dependent models based on exponential and beta‐Poisson dose–response models using MLE. The estimated parameters and the minimized deviances were determined as listed in Table 3. For data set nos. 1 and 2, the four‐parameter beta‐Poisson model with exponential‐inverse‐power DPI dependency (Eqn 6b in Table 2) proved to be the best‐fit model among the candidate models with the lowest minimized deviances and gave a statistically significant improvement in fit over the two‐ or three‐parameter models by reducing the deviance by more than or , respectively (Table 3). In contrast, the two‐parameter exponential with exponential‐inverse DPI dependency (eqn 3b in Table 2), the simplest model among the four candidate models, was judged to be the best‐fit model for data set no. 3 and 4 (Table 3).
Table 3.
Data set no. | Best‐fit model description | No. of parameters | Parameter estimates | Minimized deviance | χ2 0·95, df | |
---|---|---|---|---|---|---|
Basic model | DPI dependency | |||||
1 | beta‐Poisson | Exponential‐inverse‐power | 4 | α = 4·640 × 10−1 | 34·7 | 101·9 |
J 0 = 3·015 × 102 | ||||||
J 1 = 1·000 | ||||||
J 2 = 1·793 | ||||||
2 | beta‐Poisson | Exponential‐inverse‐power | 4 | α = 2·730 × 10−1 | 39·6 | 171·9 |
J 0 = 9·617 × 104 | ||||||
J 1 = 2·7082 | ||||||
J 2 = 4·666 | ||||||
3 | Exponential | Exponential‐inverse | 2 | k 0 = −1·707 × 101 | 15·2 | 31·4 |
k 1 = −1·502 × 10−1 | ||||||
4 | Exponential | Exponential‐inverse | 2 | k 0 = −1·480 × 101 | 3·1 | 18·307 |
k 1 = −7·092 |
DPI, days postinoculation.
Comparison between the best‐fit model and experimental data sets
The dose–response or time–response curves of the best‐fit models were compared with the observed mortalities, as shown in 1, 2, 3, 4. Although the experimental data sets include different experimental conditions of experimental animals, HPAI H5N1 virus strains and inoculation routes, the best‐fit model for each data set well predicted the observed animal responses.
Discussion
Although human infection with HPAI H5N1 virus is of a great public health concern, dose–response model of the virus has not been reported. This is partly because there are no data sets describing human challenge with wild‐type HPAI H5N1 virus because of its high mortality. This situation seems common to other pathogens with a high virulence, such as SARS coronavirus (Watanabe et al. 2010). Prior microbial dose–response studies on several pathogens, however, have demonstrated that data from animal experiments provide reasonable estimates for human susceptibility (Haas et al. 2000; Armstrong and Haas 2007; Bartrand et al. 2008). Mice have also been widely used as mammalian models to study the pathogenesis of HPAI H5N1 virus; a major advantage of this model is that infection experiments can be performed with large groups of animals, because of the relatively low cost and easy husbandry, to achieve statistical significance (Belser et al. 2009). Katz et al. (2000a) reported that H5N1‐infected mice exhibited inflammatory cell infiltration that is also observed for human fatal cases associated with HPAI H5N1 virus infection (de Jong 2008). Ferrets are excellent model to study the pathogenesis and transmissibility of influenza viruses because their clinical symptoms following influenza virus infection are similar to those of humans (Zitzow et al. 2002; Belser et al. 2009).
In the present study, we used the data sets including different experimental conditions of hosts, virus strains and inoculation routes and investigated the time‐dependent dose–response relationship of HPAI H5N1 virus. The exponential and the beta‐Poisson models, both assuming the random (i.e. Poisson) distribution of pathogens between doses (Haas et al. 1999), usually provide good fits for microbial dose–response data and have been used for risk assessment. In the present study, we constructed candidate time‐dependent models by incorporating time factor into the exponential or the beta‐Poisson model (Table 2), because it is reasonable to assume the random distribution of HPAI H5N1 virus. We found that the best‐fit model differed depending on the data set (Table 3), probably due to the difference in host, virus strain and/or inoculation route.
It should be noted that 50% mice lethal dose (MLD50) values, which are the most commonly used lethality indicator of HPAI H5N1 viruses, are highly variable from <101·5 to more than 107 depending on the strain (Lu et al. 1999; Katz et al. 2000b; Nguyen et al. 2005; Suguitan et al. 2006), suggesting that the lethality of HPAI H5N1 virus is highly variable. To calculate infection risk and disease burden accurately, it is important to understand the factors determining the transmissibility, infectivity and lethality of HPAI H5N1 viruses. Hemagglutinin (HA) receptor specificity plays an important role in the transmission of influenza viruses, and the affinity of viral HA protein for sialic acid‐α2,6‐galactose (SAα2,6‐Gal; human‐like receptors) is required for the transmission among ferrets that express SAα2,6‐Gal on respiratory tract tissues. Recent finding revealed that four influenza virus proteins, not only HA but also PB2, NS1 and PB1‐F2, are major determinants of virulence, pathogenicity and host range restriction (Neumann et al. 2010). Although only a limited number of dose–response data on HPAI H5N1 virus are available to date, future dose–response analysis on HPAI H5N1 viruses should consider these molecular factors for better understanding of their pathogenesis and transmissibility among humans. Further QMRA works on HPAI H5N1 viruses will also include the application of the dose–response model by combining with the influenza virus shedding, transportation and exposure models, as described previously (Atkinson and Wein 2008; Nicas and Jones 2009).
In conclusion, we have successfully developed the time‐dependent dose–response models of HPAI H5N1 virus, which describe the mortality over time and represent the responses of mice or ferrets accurately. The models developed in the present study, especially the models for ferrets that are excellent model to study human influenza virus infection, will be a useful tool for estimating the time‐dependent mortality of HPAI H5N1 virus, for the preparation of a future influenza pandemic caused by this lethal virus.
Acknowledgements
We acknowledge the support of the Japan Society for the Promotion of Science (JSPS) to Masaaki Kitajima, under an Excellent Young Researchers Overseas Visit Program. This work was supported in part by the US Environmental Protection Agency (EPA) and US Department of Homeland Security (DHS) under the US EPA Science to Achieve Results (STAR) grant program (grant number: R83236201). This work does not express official policy of either US EPA or DHS.
References
- Armstrong, T.W. and Haas, C.N. (2007) A quantitative microbial risk assessment model for Legionnaires’ disease: animal model selection and dose‐response modeling. Risk Anal 27, 1581–1596. [DOI] [PubMed] [Google Scholar]
- Atkinson, M.P. and Wein, L.M. (2008) Quantifying the routes of transmission for pandemic influenza. Bull Math Biol 70, 820–867. [DOI] [PubMed] [Google Scholar]
- Bartrand, T.A. , Weir, M.H. and Haas, C.N. (2008) Dose‐response models for inhalation of Bacillus anthracis spores: interspecies comparisons. Risk Anal 28, 1115–1124. [DOI] [PubMed] [Google Scholar]
- Belser, J.A. , Szretter, K.J. , Katz, J.M. and Tumpey, T.M. (2009) Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses. Adv Virus Res 73, 55–97. [DOI] [PubMed] [Google Scholar]
- van den Brand, J.M. , Stittelaar, K.J. , van Amerongen, G. , Rimmelzwaan, G.F. , Simon, J. , de Wit, E. , Munster, V. , Bestebroer, T. et al. (2010) Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis 201, 993–999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fan, S. , Deng, G. , Song, J. , Tian, G. , Suo, Y. , Jiang, Y. , Guan, Y. , Bu, Z. et al. (2009) Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology 384, 28–32. [DOI] [PubMed] [Google Scholar]
- Haas, C.N. , Rose, J.B. , Gerba, C. and Regli, S. (1993) Risk assessment of virus in drinking water. Risk Anal 13, 545–552. [DOI] [PubMed] [Google Scholar]
- Haas, C.N. , Rose, J.B. and Gerba, C.P. (1999) Quantitative Microbial Risk Assessment. New York: Wiley and Sons. [Google Scholar]
- Haas, C.N. , Thayyar‐Madabusi, A. , Rose, J.B. and Gerba, C.P. (2000) Development of a dose‐response relationship for Escherichia coli O157:H7. Int J Food Microbiol 1, 153–159. [DOI] [PubMed] [Google Scholar]
- Huang, Y. and Haas, C.N. (2009a) Time‐dose‐response models for microbial risk assessment. Risk Anal 29, 648–661. [DOI] [PubMed] [Google Scholar]
- Huang, Y. , Bartrand, T.A. , Haas, C.N. and Weir, M.H. (2009b) Incorporating time postinoculation into a dose‐response model of Yersinia pestis in mice. J Appl Microbiol 107, 727–735. [DOI] [PubMed] [Google Scholar]
- de Jong, M.D. (2008) H5N1 transmission and disease: observations from the frontlines. Pediatr Infect Dis J 27, S54–S56. [DOI] [PubMed] [Google Scholar]
- Katz, J.M. , Lu, X. , Frace, A.M. , Morken, T. , Zaki, S.R. and Tumpey, T.M. (2000a) Pathogenesis of and immunity to avian influenza A H5 viruses. Biomed Pharmacother 54, 178–187. [DOI] [PubMed] [Google Scholar]
- Katz, J.M. , Lu, X. , Tumpey, T.M. , Smith, C.B. , Shaw, M.W. and Subbarao, K. (2000b) Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J Virol 74, 10807–10810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kiso, M. , Ozawa, M. , Le, M.T. , Imai, H. , Takahashi, K. , Kakugawa, S. , Noda, T. , Horimoto, T. et al. (2011) Effect of an asparagine‐to‐serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus. J Virol 85, 4667–4672. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liem, N.T. , Tung, C.V. , Hien, N.D. , Hien, T.T. , Chau, N.Q. , Long, H.T. , Hien, N.T. , Le, Q.M. et al. (2009) Clinical features of human influenza A (H5N1) infection in Vietnam: 2004–2006. Clin Infect Dis 48, 1639–1649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lu, X. , Tumpey, T.M. , Morken, T. , Zaki, S.R. , Cox, N.J. and Katz, J.M. (1999) A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol 73, 5903–5911. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neumann, G. , Chen, H. , Gao, G.F. , Shu, Y. and Kawaoka, Y. (2010) H5N1 influenza viruses: outbreaks and biological properties. Cell Res 20, 51–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nguyen, D.C. , Uyeki, T.M. , Jadhao, S. , Maines, T. , Shaw, M. , Matsuoka, Y. , Smith, C. , Rowe, T. et al. (2005) Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol 79, 4201–4212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nicas, M. and Jones, R.M. (2009) Relative contributions of four exposure pathways to influenza infection risk. Risk Anal 29, 1292–1303. [DOI] [PubMed] [Google Scholar]
- Suguitan, A.L. Jr , McAuliffe, J. , Mills, K.L. , Jin, H. , Duke, G. , Lu, B. , Luke, C.J. , Murphy, B. et al. (2006) Live, attenuated influenza A H5N1 candidate vaccines provide broad cross‐protection in mice and ferrets. PLoS Med 73, 5903–5911. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Teunis, P.F. , Chappell, C.L. and Okhuysen, P.C. (2002) Cryptosporidium dose response studies: variation between isolates. Risk Anal 22, 175–183. [DOI] [PubMed] [Google Scholar]
- Wang, X. , Zhao, J. , Tang, S. , Ye, Z. and Hewlett, I. (2010) Viremia associated with fatal outcomes in ferrets infected with avian H5N1 influenza virus. PLoS ONE 5, e12099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watanabe, T. , Bartrand, T.A. , Weir, M.H. , Omura, T. and Haas, C.N. (2010) Development of a dose‐response model for SARS coronavirus. Risk Anal 30, 1129–1138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright, P.F. , Neumann, G. and Kawaoka, Y. (2007) Orthomyxoviruses In Fields Virology ed. Knipe D. and Howley P. pp. 949–979 Philadelphia: Lippincott Williams and Wilkins. [Google Scholar]
- Yang, Y. , Halloran, M.E. , Sugimoto, J.D. and Longini, I.M.. Jr (2007) Detecting human‐to‐human transmission of avian influenza A (H5N1). Emerg Infect Dis 13, 1348–135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zitzow, L.A. , Rowe, T. , Morken, T. , Shieh, W.J. , Zaki, S. and Katz, J.M. (2002) Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J Virol 76, 4420–4429. [DOI] [PMC free article] [PubMed] [Google Scholar]